GoodRx Holdings (GDRX) Operating Expenses (2019 - 2026)

GoodRx Holdings has disclosed Operating Expenses across 8 years of filings, most recently posting $176.8 million for Q2 2026.

• In Q2 2026, Operating Expenses changed 0.29% year-over-year to $176.8 million; the TTM figure through Jun 2026 stood at $710.3 million (changed 0.11% YoY), while the FY2025 annual figure was $709.4 million, down 2.36% from the prior year.
• Operating Expenses came in at $176.8 million for Q2 2026 at GoodRx Holdings, down from $180.0 million in the prior quarter.
• In the past five years, Operating Expenses ranged from a high of $218.3 million in Q3 2023 to a low of $171.4 million in Q2 2023.
• Average Operating Expenses over 5 years is $185.3 million, with a median of $180.6 million recorded in 2024.
• Year-over-year, Operating Expenses grew 17.85% in 2023 and declined 19.9% in 2024.
• Over 5 years, Operating Expenses stood at $182.4 million in 2022, then gained by 17.85% to $214.9 million in 2023, then decreased by 16.07% to $180.4 million in 2024, then dropped by 4.6% to $172.1 million in 2025, then rose by 2.72% to $176.8 million in 2026.
• Per Business Quant data, the three most recent Operating Expenses figures were $176.8 million in Q2 2026, $180.0 million in Q1 2026, and $172.1 million in Q4 2025.